Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

MEHA stock news

This page provides real-time market news, earnings updates, and company announcements related to Functional Brands, Inc. (MEHA).

All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.

Last updated as of 2026-04-16 05:29 EST

Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference image

Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference

Finviz2026-04-08 20:09:50
Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents image

Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents

Finviz2026-04-09 11:51:48
LOBO Launches Claw AI Agent Platform to Accelerate AI Adoption in Export-Oriented Manufacturing image

LOBO Launches Claw AI Agent Platform to Accelerate AI Adoption in Export-Oriented Manufacturing

Finviz2026-04-09 12:03:55
NeurAxis, Inc. Announces Preferred Stock Dividend image

NeurAxis, Inc. Announces Preferred Stock Dividend

Finviz2026-04-10 11:03:13
Innovative Eyewear, Inc. Receives NHPA Retailer's Choice Award for Lucyd Armor Smart Safety Eyewear image

Innovative Eyewear, Inc. Receives NHPA Retailer's Choice Award for Lucyd Armor Smart Safety Eyewear

Finviz2026-04-10 12:03:46
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity image

FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity

Finviz2026-04-10 12:36:05
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION image

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION

Finviz2026-04-10 20:12:45
Ocular Therapeutix Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI in Wet AMD image

Ocular Therapeutix Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI in Wet AMD

Finviz2026-04-13 11:03:46
Lakeland Fire + Safety Appoints Kevin Rae to Executive Vice President, EMEA Fire Sales image

Lakeland Fire + Safety Appoints Kevin Rae to Executive Vice President, EMEA Fire Sales

Finviz2026-04-13 12:33:38
Commvault Announces Leadership Appointments image

Commvault Announces Leadership Appointments

Finviz2026-04-13 12:33:40
New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients image

New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients

Finviz2026-04-13 13:03:12
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition image

BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

Finviz2026-04-13 13:21:41
Microchip Expands dsPIC33A DSC Family for High-Density AI Data Center Power, Complex Motor Control and Intelligent Sensing image

Microchip Expands dsPIC33A DSC Family for High-Density AI Data Center Power, Complex Motor Control and Intelligent Sensing

Finviz2026-04-14 10:18:49
Dow Chair and CEO Jim Fitterling to Become Executive Chair; Karen S. Carter Appointed Chief Executive Officer image

Dow Chair and CEO Jim Fitterling to Become Executive Chair; Karen S. Carter Appointed Chief Executive Officer

Finviz2026-04-14 10:33:58
Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway image

Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway

Finviz2026-04-14 11:00:53
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer's Disease image

Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer's Disease

Finviz2026-04-14 11:33:41
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026 image

Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026

Finviz2026-04-14 12:06:46
MasterCraft Reintroduces the All-New X23, an Iconic Platform Reimagined for the Modern X Family Lineup image

MasterCraft Reintroduces the All-New X23, an Iconic Platform Reimagined for the Modern X Family Lineup

Finviz2026-04-14 15:03:41
According to informed sources, Disney will carry out a new round of layoffs, and this adjustment will broadly affect multiple core business sectors. image

According to informed sources, Disney will carry out a new round of layoffs, and this adjustment will broadly affect multiple core business sectors.

老虎证券2026-04-14 15:22:07
Lululemon Faces "Carcinogen" Investigation Crisis: The High-End Yoga Pants Myth Faces a Trust Test image

Lululemon Faces "Carcinogen" Investigation Crisis: The High-End Yoga Pants Myth Faces a Trust Test

金融界2026-04-14 23:55:38

MEHA stock chart

MEHA stock details

MEHA stock price change

On the last trading day, MEHA stock closed at 0.13 USD, with a price change of 4.79% for the day.

Trade stock perps

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
MEHA stock news